Molecular Instruments
PrivateLast Round
VC Round
Aug 26, 2020
Total Funding Raised
$1.41M
Company Overview
Molecular Instruments operates in Healthcare & Life Sciences and is based in Los Angeles, California. Its latest recorded funding round was a VC Round in August 2020.
Molecular Instruments is a biotechnology company that develops and synthesizes molecular kits powered by its proprietary HCR imaging platform for applications in academic research, drug development, and clinical diagnostics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery, Medical Imaging
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Molecular Instruments Comparables
Compare Molecular Instruments with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vizgen | 81% | |
| Resolve Biosciences | 79% | |
| Stellaromics | 79% |
For institutional investors. Book with your work email.
Molecular Instruments Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Molecular Instruments Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| Freeflow Ventures | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 18, 2026
Monthly visitors grew 37% MoM, reaching 9.9K.
For institutional investors. Book with your work email.
Molecular Instruments Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Molecular Instruments's valuation, stock price, and market status.
Is Molecular Instruments a public or private company?
Molecular Instruments is a private company.
What is the current stock price of Molecular Instruments?
Molecular Instruments is a private company, so its shares have no public market price. Caplight tracks Molecular Instruments's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Molecular Instruments worth (valuation)?
Valuation information for Molecular Instruments is not publicly available.
Can I buy Molecular Instruments stock?
Molecular Instruments shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Molecular Instruments's last funding round?
Molecular Instruments's most recent funding round was VC Round on August 26, 2020.
Who are the main investors in Molecular Instruments?
Key investors in Molecular Instruments include NIH RADx, Freeflow Ventures.
Will Molecular Instruments IPO soon?
No public IPO plans have been announced for Molecular Instruments.
How can I track Molecular Instruments secondary market activity?
Caplight tracks bids, offers, and trades in Molecular Instruments's shares on secondary markets.